Cognitive behavior therapy in medication non-responders with obsessive–compulsive disorder: A prospective 1-year follow-up study

Highlights ► Efficacy of CBT in OCD non-responsive to multiple SRIs is not well studied. ► CBT was efficacious in patients non-responsive to multiple SRIs and augmenting drugs. ► CBT had enduring effects with 61% maintaining response at 1-year follow-up. ► Compliance to treatment and less severe ill...

Full description

Saved in:
Bibliographic Details
Published in:Journal of anxiety disorders 2011-10, Vol.25 (7), p.939-945
Main Authors: Anand, Nitin, Sudhir, Paulomi M, Math, Suresh Bada, Thennarasu, K, Janardhan Reddy, Y.C
Format: Article
Language:English
Subjects:
Adult
Adult and adolescent clinical studies
Anxiety disorders. Neuroses
Behavior therapy. Cognitive therapy
Biological and medical sciences
Cognitive behaviour therapy
Cognitive Therapy
Cognitive-behavior therapy
Combined Modality Therapy
Compliance
Efficacy
Female
Fluoxetine - therapeutic use
Follow-Up Studies
Humans
Male
Medical sciences
Obsessive-Compulsive Disorder - drug therapy
Obsessive-Compulsive Disorder - psychology
Obsessive-Compulsive Disorder - therapy
Obsessive-compulsive disorders
Obsessive-Compulsive neuroses
Obsessive–compulsive disorder
Prospective Studies
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Remission
Serotonin Uptake Inhibitors - therapeutic use
Severity
SRI non-response
Treatment Outcome
Treatments
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights ► Efficacy of CBT in OCD non-responsive to multiple SRIs is not well studied. ► CBT was efficacious in patients non-responsive to multiple SRIs and augmenting drugs. ► CBT had enduring effects with 61% maintaining response at 1-year follow-up. ► Compliance to treatment and less severe illness predicted remission to CBT. ► Predictors of response to CBT need to be studied further in larger controlled trials.
ISSN:0887-6185
1873-7897
DOI:10.1016/j.janxdis.2011.05.007